Elsa Calcaterra
Messina, 98166, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Macrocycles and stapled-peptides in the fight against SARS-CoV-2: a review.
Journal: European journal of medicinal chemistry
Published: February 09, 2026
The promising role of cathepsins as biomarkers and therapeutic targets in glioblastoma.
Journal: Discover oncology
Published: January 25, 2026
A Second Opportunity for the Peptide-Based Analogues with γ-Lactam at the P1 Position: Human Cathepsin S Inhibition.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 10, 2025
The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy.
Journal: Biomedicines
Published: July 24, 2025
Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models.
Journal: Journal of cellular and molecular medicine
Published: May 23, 2025
The Therapeutic Potential of MicroRNA-21 in the Treatment of Spinal Cord Injury.
Journal: Current issues in molecular biology
Published: December 18, 2024
Identification of constrained peptidomimetics carrying a Michael acceptor warhead as antitrypanosomal agents.
Journal: European journal of medicinal chemistry
Published: December 06, 2024
Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents.
Journal: ACS medicinal chemistry letters
Published: December 15, 2023
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors.
Journal: European journal of medicinal chemistry
Published: November 08, 2022
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain.
Journal: ACS medicinal chemistry letters
Published: July 21, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026